The ex vivo responsiveness of PBMCs to TLR4- and T cell-receptor activation, as measured by ELISpot quantification of both TNF-alpha and IFN-gamma respectively, differed between SARS-CoV-2 and bacterial sepsis patients. The gene discussed is TLR4; the disease is bacterial infectious disease with sepsis.